The CDC Guidelines Recommend Informing ALL Sexually Active Adults and Adolescents and ALL Injection Drug Users About PrEP.1
The CDC guidelines state to use the following criteria to identify if adults and adolescents weighting at least 35 kg are candidates for PrEP.
Please note: People who request PrEP should be offered it, even when no risk behaviors are identified. Studies have shown that people may not disclose certain behaviors to their health care provider even though they are at risk. Those criteria include people who are confirmed to be HIV-negative* and:
Are sexually active (anal or vaginal sex in the past 6 months) AND have any of the following:
- Sexual partner(s) living with HIV (especially if their viral load is detectable or unknown)
- Bacterial STI in the past 6 months
- History of inconsistent or no condom use with sexual partner(s)
Are people who inject drugs and:
- Have an injection partner who is living with HIV
Or
- Share injection equipment
Or
- are assessed to have sexual risk of HIV acquisition
* It is vital that people who may benefit from PrEP (PWBP) have a documented negative HIV test (ideally with a laboratory-based combination HIV antigen/antibody test) result within 1 week before receiving their initial PrEP dose and must not have any signs or symptoms of acute HIV infection.2 PWBP must also meet clinical eligibility based on the product they choose with their prescriber, which may require additional testing.
As new PrEP products are approved by FDA, please be aware there may be a delay in resources and guideline updates
References:
- Centers for Disease Control and Prevention (CDC). Pre-exposure prophylaxis (PrEP). Updated June 11, 2021. Accessed October 26, 2021. https://www.cdc.gov/hiv/clinicians/prevention/
- Department of Health and Human Services. Symptoms of HIV. Updated July 1, 2020. Accessed October 13, 2021. https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/symptoms-of-hiv
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.